CSL — Csl Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapFalling Star

Annual income statement for Csl, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	C2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,151	10,310	10,562	13,310	14,800
Cost of Revenue
Gross Profit	5,226	5,843	5,732	6,825	7,671
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	6,434	7,180	7,635	10,241	10,988
Operating Profit	2,717	3,130	2,927	3,069	3,812
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,573	2,963	2,780	2,663	3,375
Provision for Income Taxes
Net Income After Taxes	2,103	2,375	2,255	2,244	2,714
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,103	2,375	2,255	2,194	2,642
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	2,103	2,375	2,255	2,194	2,642
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.95	5.37	5.03	4.53	5.45
Dividends per Share